+50 RESEARCH LINES
Regemat 3D aims to achieve clinical results through the application of 3D bioprinting that aims to:
Regemat 3D, founded in 2011, has the mission to design and develop innovative solutions in the area of bioprinting and regenerative medicine through the clinical application of this technology. A cutting-edge technology, which provides specific solutions for researchers, with the ultimate goal of improving the quality of life of patients .
Leading the field of regenerative medicine through the
continuous innovation of technologies which allows the application
continuous custom-made solutions.
Regemat 3D is a leading company and Pioneer in the bioprinting for the healthcare sector, run by a multidisciplinar team in advanced therapies, regenerative medicine, tissue engineering, regulatory and medical devices commercialization.
We are the only company what design and manufacture medical devices for clinical applications and also develop bioprinting systems. Currently, we are specialized in the implementation of biofabrication strategies thanks to the experience and complementarity of our corporate group: BRECA Health Care we design and produce personalized medical devices (Prosthesis, cutting guides and biomodels) with more than 10 years of experience and more than 100 clinical cases which back us into the application of 3D printing technologies, 3D bioprinting and tailor-made bioreactors (REGEMAT 3D)
We transform your research results into functional solutions which add value to the development of great strides in the fields of the biofabrication and regenerative medicine.